Evolution of HIV/AIDS prevention programs - United States, 1981-2006

Morbidity and Mortality Weekly Report

Volumn 55, Issue 21, 2006, Pages 597-603

  Wolitski, R J ^a   Henny, K D ^a   Lyles, C M ^a   Purcell, D W ^a   Carey, J W ^a   Crepaz, N ^a   O'Leary, A ^a   Mastro, T D ^a   Cleveland, J C ^a   Nakashima, A K ^a   Janssen, R S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; UNITED STATES;

COMMUNICABLE DISEASE CONTROL; HIV INFECTIONS; HUMANS; UNITED STATES;

EID: 33744488266     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Valdiserri RO, Robinson C, Lin LS, West GR, Holtgrave DR. Determining allocations for HIV-prevention interventions: assessing a change in federal funding policy. AIDS Public Policy J 1997;12:138-48.
2. Shilts R. And the band played on. New York, NY: St. Martin's Press; 1987.
3. Mason JO, Noble GR, Lindsey BK, et al. Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education. Public Health Rep 1988;103:255-63.
4. Wolitski RJ, Janssen RS, Holtgrave DR, Peterson JL. The public health response to the HIV epidemic in the U.S. In: Wormser GP, ed. AIDS and other manifestations of HIV infection. 4th ed. San Diego, CA: Elsevier Academic Press; 2004:997-1012.
5. CDC AIDS Community Demonstration Project Research Group. Community-level HIV intervention in 5 cities: final outcome data from the CDC AIDS Community Demonstration Projects. Am J Public Health 1999;89:336-45.
6. Herbst JH, Sherba RT, Crepaz N, et al. A meta-analytic review of HIV behavioral interventions for reducing sexual risk behavior of men who have sex with men. J Acquir Immune Defic Syndr 2005;39:228-41.
7. Mullen PD, Ramirez G, Strouse D, Hedges LG, Soglow E. Meta-analysis of the effects of behavioral HIV prevention interventions on the sexual risk behavior of sexually experienced adolescents in controlled studies in the United States. J Acquir Immune Defic Syndr 2002;30(Suppl 1):S94-S105.
8. Neumann MS, Johnson WD, Semaan S, et al. Review and meta-analysis of HIV prevention intervention research for heterosexual adult populations in the United States. J Acquir Immune Defic Syndr 2002;30(Suppl 1):S106-S117.
9. Semaan S, DesJarlais DC, Sogolow E, et al. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr 2002;30(Suppl 1):S73-S93.
10. CDC. Compendium of HIV prevention interventions with evidence of effectiveness. Atlanta, GA: US Department of Health and Human Services, CDC; 1999 (Revised 2001). Available at http://www.cdc.gov/hiv/pubs/HIVcompendium/ hivcompendium.pdf.
11. Kay LS, Crepaz N, Lyles CM, et al. Update of the compendium of HIV prevention interventions with evidence of effectiveness. In: Proceedings of National HIV Prevention Conference, Atlanta, GA, July 27-30, 2003.
12. Lyles CM, Kay LS, Crepaz N, et al. Best evidence interventions: findings from a systematic review of HIV behavioral interventions for U.S. populations at high risk, 2000-2004. Am J Public Health. In press, 2006.
13. Eke AN, Neumann MS, Wilkes AL, Jones PL. Preparing effective behavioral interventions to be used by prevention providers: the role of researchers during HIV prevention trials. AIDS Educ Prev. In press, 2006.
14. Neumann MS, Sogolow ED. Replicating effective programs: HIV/AIDS prevention technology transfer. AIDS Educ Prev 2000;12(Suppl A):S35-48.
15. Collins C, Harshbarger C, Sawyer R, Hamdallah M. The diffusion of effective behavioral interventions project: development, implementation, and lessons learned. AIDS Ed Prev. In press, 2006.
16. Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868-71.
17. Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984;224:500-3.
18. CDC. Provisional public health service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. MMWR 1985;34:1-5.
19. CDC. Human t-lymphotropic virus type III/lymphadenopathy-associated virus antibody testing at alternate sites. MMWR 1986;35:284-7.
20. CDC. Additional recommendations to reduce sexual and drug abuse-related transmission of human t-lymphotropic virus type III/lymphadenopathy-associated virus. MMWR 1986;35:152-5.
21. Sullivan PS, Lansky A, Drake A, HITS-2000 Investigators. Failure to return for HIV test results among persons at high risk for HIV infection: results from a multistate interview project. J Acquir Immune Defic Syndr 2004;35:511-8.
22. Wolitski RJ, Janssen RS, Onorato IM, Purcell DW, Crepaz N. A comprehensive approach to prevention with people living with HIV. In: Kalichman SC, ed. Positive prevention: reducing HIV transmission among people living with HIV/AIDS. New York, NY: Kluwer Academic/Plenum Publishers; 2005:1-28.
23. Weinhardt L, Carey M, Johnson B, Bickman N. Effects of HIV counseling and testing on sexual risk behavior: A meta-analytic review of published research, 1985-1997. Am J Public Health 1999; 89:1397-405.
24. CDC. HIV counseling, testing and referral standards and guidelines. Atlanta, GA: US Department of Health and Human Services, CDC; 1994.
25. Kamb ML, Fishbein M, Douglas JM Jr, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA 1998;280:1161-7.
26. CDC. Advancing HIV prevention: new strategies for a changing epidemic - United States, 2003. MMWR 2003;52:329-32.
27. CDC. Provisional procedural guidance for community-based organizations. Atlanta, GA: US Department of Health and Human Services, CDC; 2006. Available at http://www.cdc.gov/hiv/topics/prev_prog/ahp/resources/guidelines/pro_guidance. htm.
28. Wurcel A, Zama T, Zhen S, Stone D. Acceptance of HIV antibody testing among inpatients and outpatients at a public health hospital: a study or rapid versus standard testing. AIDS Patient Care STDs 2005;19:499-505.
29. Metcalf CA, Douglas JM Jr, Malotte CK, et al. Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sex Trans Dis 2005;32:130-8.
30. Glynn M, Rhodes P. What is really happening with HIV trends in the United States? Modeling the national epidemic. In: Proceedings of National HIV Prevention Conference, Atlanta, GA, June 12-15, 2005.
31. Weinhardt LS. HIV diagnosis and risk behavior. In: Kalichman SC, ed. Positive prevention: reducing HIV transmission among people living with HIV/AIDS. New York, NY: Kluwer Academic/Plenum Publishers; 2005:29-63.
32. Janssen RS, Holtgrave DR, Valdiserri RO, Shepherd M, Gayle HD. The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. Am J Public Health 2001;91:1019-24.
33. CDC. Incorporating HIV prevention into the medical care of persons living with HIV: recommendation of CDC, the health resources and services administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2003;52(No. RR-12).
34. Crepaz N, Lyles CM, Wolitski RJ, et al. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS 2006;20:143-57.
35. CDC. Reduction in perinatal transmission of HIV infection - United States, 1985-2005. MMWR 2006;55:592-6.
36. Monterroso ER, Hamburger ME, Vlahov D, et al. Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). J Acquir Immune Defic Syndr 2000;25:63-70.
37. CDC. Trends in HIV/AIDS diagnoses - 33 states, 2001-2004. MMWR 2005;54:1149-53.
38. CDC. Racial/ethnic disparities in diagnoses of HIV/AIDS - 33 states, 2001-2004. MMWR 2006;55:121-5.
39. CDC. HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men - five U.S. cities, June 2004-April 2005. MMWR 2005;54:597-601.
40. Sumartojo E. Structural factors in HIV prevention: Concepts, examples, and implications for research. AIDS 2000;14(Suppl 1):S3-10.
41. Valdiserri RO. HIV/AIDS stigma: an impediment to public health. Am J Public Health 2002;92:341-2.
42. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Med 2005;2:e298.